Skip to main content
TipRanks
Go Ultimate75% OFF

Viridian Therapeutics (VRDN) Financial Statements

1,573 Followers

Viridian Therapeutics Financial Overview

Viridian Therapeutics's market cap is currently $3.41B. The company's EPS TTM is $-3.87; its P/E ratio is -7.71; Viridian Therapeutics is estimated to report earnings on March 11, 2027, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 70.85M$ 302.00K$ 314.00K$ 1.77M$ 2.96M
Gross Profit$ 70.85M$ 302.00K$ 314.00K$ 1.77M$ 2.96M
Operating Income$ -363.39M$ -299.04M$ -254.45M$ -134.30M$ -79.73M
EBITDA$ -337.19M$ -266.36M$ -235.37M$ -129.13M$ -79.29M
Net Income$ -342.60M$ -269.95M$ -237.73M$ -129.87M$ -79.41M
Balance Sheet
Cash & Short-Term Investments$ 874.65M$ 717.58M$ 477.37M$ 424.55M$ 196.97M
Total Assets$ 899.42M$ 742.40M$ 490.42M$ 435.09M$ 203.71M
Total Debt$ 50.69M$ 21.09M$ 21.05M$ 5.26M$ 1.04M
Net Debt$ -161.69M$ -78.50M$ -81.78M$ -150.32M$ -41.26M
Total Liabilities$ 177.25M$ 70.76M$ 48.40M$ 40.03M$ 15.99M
Stockholders' Equity$ 722.17M$ 671.64M$ 442.02M$ 395.06M$ 187.72M
Cash Flow
Free Cash Flow$ -276.89M$ -232.83M$ -185.07M$ -94.64M$ -54.92M
Operating Cash Flow$ -276.39M$ -232.32M$ -184.17M$ -93.84M$ -54.58M
Investing Cash Flow$ -37.56M$ -228.65M$ -94.25M$ -115.13M$ -74.29M
Financing Cash Flow$ 426.74M$ 457.74M$ 225.67M$ 322.24M$ 125.28M

Currency in USD

Viridian Therapeutics Earnings and Revenue History

-400M-200M0200M-120000 %-80000 %-40000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Viridian Therapeutics Liabilities to Assets

0400M800M1.2B0 %20 %40 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Viridian Therapeutics Cash Flow

-400M-200M0200M400M600M201720182019202020212022202320242025OperatingInvestingFinancing

Viridian Therapeutics Forecast EPS vs Actual EPS

-1.2-1-0.8-0.6-0.4-0.2Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss